Von Hippel-Lindau (VHL) syndrome is a genetic condition associated with tumors such as hemangioblastomas, pheochromocytomas, renal cell carcinomas, endolymphatic sac tumors, and islet cell tumors. Hemangioendotheliomas are vascular tumors not characteristic of VHL syndrome, making option C the correct exception.